Meribank Biotech Co., Ltd carries a market capitalization of 950.17M, placing it among publicly traded companies globally.
| Market Cap | 950.17M |
| Enterprise Value | N/A |
Meribank Biotech Co., Ltd's stock has declined approximately -40.36145% over the past 52 weeks. The 50-day moving average sits at 11.70, while the 200-day moving average is 14.98.
| Beta (5Y) | N/A |
| 52-Week Price Change | -40.36145% |
| 50-Day Moving Average | 11.70 |
| 200-Day Moving Average | 14.98 |
| Average Volume (20 Days) | N/A |